{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:08:02Z","timestamp":1776402482593,"version":"3.51.2"},"reference-count":72,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":1614,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006182","name":"Funda\u00e7\u00e3o Estadual de Amparo \u00e0 Pesquisa do Estado do Esp\u00edrito Santo","doi-asserted-by":"publisher","award":["54685532\/2011"],"award-info":[{"award-number":["54685532\/2011"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["482167\/2013-0"],"award-info":[{"award-number":["482167\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.micinf.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T05:29:19Z","timestamp":1551072559000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis"],"prefix":"10.1016","volume":"21","author":[{"given":"Caio Loureiro","family":"Salgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanoel Loss","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzzo Lyrio","family":"Stringari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Polaco","family":"Covre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reynaldo","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto Edmundo","family":"Lima Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbet Leonel","family":"de Matos Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Claudio Oliveira","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2019.02.005_bib1","series-title":"OMS|leishmaniasis","first-page":"375","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.micinf.2019.02.005_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2018.02.010","article-title":"Recent progress in drug targets and inhibitors towards combating leishmaniasis","volume":"181","author":"Vijayakumar","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.micinf.2019.02.005_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.micinf.2019.02.005_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2010.08.014","article-title":"Innate immunity and leishmania vaccination strategies","volume":"29","author":"Birnbaum","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.micinf.2019.02.005_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","article-title":"Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum","volume":"33","author":"Fiuza","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132794","article-title":"Evaluation of live recombinant nonpathogenic leishmania tarentolae expressing cysteine proteinase and A2 genes as a candidate vaccine against experimental canine visceral leishmaniasis","volume":"10","author":"Shahbazi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.apjtm.2017.09.001","article-title":"A\u00a0new approach for development of vaccine against visceral leishmaniasis: lipophosphoglycan and polyacrylic acid conjugates","volume":"10","author":"Allahverdiyev","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.micinf.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.micinf.2019.02.005_bib10","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/S0264-410X(03)00427-4","article-title":"Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB\/c and C57BL\/6 mice against cutaneous leishmaniasis","volume":"21","author":"Pinto","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK","volume":"72","author":"Pinto","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"Pinheiro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/1756-3305-7-448","article-title":"Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB\/c mice against infection","volume":"7","author":"Matos Guedes","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib14","first-page":"264","article-title":"Serine proteases and vaccines against Leishmaniasis\u202f: a dual role","volume":"6","author":"Chaves","year":"2015","journal-title":"J\u00a0Vaccines Vaccin"},{"key":"10.1016\/j.micinf.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1017\/S0031182015001250","article-title":"Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB\/c mice challenged with Leishmania (infantum) chagasi","volume":"142","author":"Leal","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2019.02.005_bib16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13071-016-1822-9","article-title":"Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice","volume":"9","author":"Pratti","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","article-title":"Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines","volume":"169","author":"Zeng","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/infdis\/jir548","article-title":"Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against mycobacterium tuberculosis by evoking enduring memory T-cell response","volume":"204","author":"Gowthaman","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018833","article-title":"Tlr2-dependent induction of il-10 and foxp3+cd25+cd4+ regulatory t cells prevents effective anti-tumor immunity induced by pam2 lipopeptides in\u00a0vivo","volume":"6","author":"Yamazaki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1371\/journal.pntd.0001204","article-title":"TLR1\/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T cell responses providing protection against Leishmania (Viannia)","volume":"5","author":"Jayakumar","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13071-016-1381-0","article-title":"The TLR2\/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models","volume":"9","author":"Halliday","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003546","article-title":"Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice","volume":"9","author":"Huang","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00436-005-0008-8","article-title":"Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-\u03b3 production but does not protect BALB\/c mice against Leishmania chagasi intravenous challenge","volume":"98","author":"Marques-Da-Silva","year":"2005","journal-title":"Parasitol Res"},{"key":"10.1016\/j.micinf.2019.02.005_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.micinf.2019.02.005_bib26","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2006.11.060","article-title":"Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice","volume":"25","author":"Gomes","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.vaccine.2016.04.018","article-title":"Intranasal vaccination with adjuvant-free S.\u00a0aureus antigens effectively protects mice against experimental sepsis","volume":"34","author":"Stegmiller","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2017.0022","article-title":"Intranasal administration of whole inactivated influenza virus vaccine as a promising influenza vaccine candidate","volume":"30","author":"Ainai","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib29","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/j.vaccine.2017.10.095","article-title":"Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.vaccine.2011.11.054","article-title":"Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands","volume":"30","author":"Shafique","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib31","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1128\/JVI.05060-11","article-title":"Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen","volume":"85","author":"Winstone","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2019.02.005_bib32","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/eji.200939627","article-title":"Frontline TLR2 engagement on memory CD8+ T cells improves their cytokine-mediated proliferation and IFN-\u03b3 secretion in the absence of Ag","volume":"39","author":"Cottalorda","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri2569","article-title":"Signalling through C-type lectin receptors: shaping immune responses","volume":"9","author":"Geijtenbeek","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pbi.2009.06.003","article-title":"Early molecular events in PAMP-triggered immunity","volume":"12","author":"Zipfel","year":"2009","journal-title":"Curr Opin Plant Biol"},{"key":"10.1016\/j.micinf.2019.02.005_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrc2541","article-title":"Toll-like receptors and cancer","volume":"9","author":"Rakoff-Nahoum","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.micinf.2019.02.005_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nri2436","article-title":"Viral evasion and subversion of pattern-recognition receptor signalling","volume":"8","author":"Bowie","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib37","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1172\/JCI27203","article-title":"Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance","volume":"116","author":"Dillon","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micinf.2019.02.005_bib38","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.4049\/jimmunol.1801185","article-title":"Suppression of Th1 priming by TLR2 agonists during cutaneous immunization is mediated by recruited CCR2 monocytes","volume":"201","author":"Johndrow","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib39","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.172.8.4733","article-title":"A\u00a0Toll-like receptor 2 ligand stimulates Th2 responses in\u00a0vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells","volume":"172","author":"Dillon","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.micinf.2019.02.005_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13071-016-1822-9","article-title":"Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice","volume":"6","author":"Pratti","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13071-017-2062-3","article-title":"The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs","volume":"10","author":"Mart\u00ednez-Orellana","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib42","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.4049\/jimmunol.1301262","article-title":"TLR1\/2 ligand\u00a0\u2212 stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8\u00a0+ T cell immunity in\u00a0vitro","volume":"191","author":"Liu","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nyl\u00e9n","year":"2010","journal-title":"J\u00a0Glob Infect Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of Toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano rherapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.micinf.2019.02.005_bib45","doi-asserted-by":"crossref","first-page":"e0180073","DOI":"10.1371\/journal.pone.0180073","article-title":"Combination of poly I:C and Pam3CSK4 enhances activation of B cells in\u00a0vitro and boosts antibody responses to protein vaccines in\u00a0vivo","volume":"12","author":"Weir","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2019.02.005_bib46","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.4049\/jimmunol.135.3.2108","article-title":"Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB\/c mice","volume":"135","author":"Titus","year":"1985","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib47","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.4049\/jimmunol.136.8.3067","article-title":"Prophylactic treatment of BALB\/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major","volume":"136","author":"Behforouz","year":"1986","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib48","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/intimm\/6.10.1535","article-title":"Intravenous injection of irradiated leishmania major into susceptible BALB\/c mice: immunization or protective tolerance","volume":"6","author":"Aebischer","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib49","doi-asserted-by":"crossref","first-page":"e3439","DOI":"10.1371\/journal.pntd.0003439","article-title":"Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against leishmania (Viannia) braziliensis infection","volume":"9","author":"da Silva-Couto","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib50","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1017\/S0031182011001417","article-title":"Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi","volume":"138","author":"De Oliveira Gomes","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2019.02.005_bib51","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib52","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/IAI.70.4.2151-2158.2002","article-title":"Early enhanced Th1 response after Leishmania amazonensis infection of C57BL\/6 interleukin-10-deficient mice does not lead to resolution of infection","volume":"70","author":"Jones","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib53","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1128\/IAI.72.8.4455-4463.2004","article-title":"CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing","volume":"72","author":"Vanloubbeeck","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib54","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization\u202f: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2019.02.005_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/S0037-86822003000200001","article-title":"Identification and purification of immunogenic proteins from nonliving promastigote polyvalent Leishmania vaccine (Leishvacin\u00ae)","volume":"36","author":"Regina","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.micinf.2019.02.005_bib56","first-page":"85","article-title":"Development of Leishmania vaccines: predicting the future from past and present experience","volume":"27","author":"Mutiso","year":"2013","journal-title":"J\u00a0Biomed Res"},{"key":"10.1016\/j.micinf.2019.02.005_bib57","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major","volume":"24","author":"Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib58","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/eji.200323825","article-title":"Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase","volume":"33","author":"Blos","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S0031182009990473","article-title":"The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs)","volume":"136","author":"Kavoosi","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2019.02.005_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13071-016-1472-y","article-title":"Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection","volume":"9","author":"Roma","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.micinf.2019.02.005_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm0202-166","article-title":"IL-4-secreting CD4+T cells are crucial to the development of CD8+T-cell responses against malaria liver stages","volume":"8","author":"Carvalho","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2019.02.005_bib62","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor \u03b1 signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"St\u00e4ger","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59\u00ae adjuvant: a phoenix that arose from the ashes","volume":"12","author":"O'Hagan","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2019.02.005_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-3024.2007.00991.x","article-title":"CD8 cytotoxic T cells in cutaneous leishmaniasis","volume":"29","author":"Ruiz","year":"2007","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib65","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1017\/S0031182012000868","article-title":"Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis","volume":"139","author":"De Oliveira Gomes","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.micinf.2019.02.005_bib66","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.4049\/jimmunol.174.11.7147","article-title":"CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection","volume":"174","author":"Ji","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation","volume":"40","author":"Deak","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib68","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2019.02.005_bib69","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3389\/fimmu.2017.01788","article-title":"Immunization with live attenuated Leishmania donovani centrin\u2212\/\u2212 parasites is efficacious in asymptomatic infection","volume":"8","author":"Ismail","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib70","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2019.02.005_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3024.2007.00940.x","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis","volume":"29","author":"Carvalho","year":"2007","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.micinf.2019.02.005_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vetimm.2006.10.003","article-title":"IL-6 and TNF-\u03b1 production during active canine visceral leishmaniasis","volume":"115","author":"de Lima","year":"2007","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457919300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457919300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:36:47Z","timestamp":1761143807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457919300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1286457919300279"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2019.02.005","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}